Home

A supplement in Cancer highlights the work of the National Cancer Institute’s Cancer Treatment Tolerability Consortium. This special issue features innovative approaches to measuring tolerability using both clinician- and patient-reported outcomes. These articles offer tools, predictive models, and visualization techniques that help clarify how treatment side effects influence patient experiences and treatment decisions.

Applications to use data and serum samples from phase 1 of the Military Aviators Cancer Study are being accepted through the NCI Cancer Data Access System. This retrospective cohort study looked at inicdence of cancer among military aviators and aviation support personnel. Nearly 900,000 service members provided over 6 million serum sample as well as demographic data for this study.

This series is aimed at bringing together interdisciplinary researchers in cancer symptom science to share their expertise and further discussions in the field.